Dissecting the role for IL-15 in CD8+ T cell homeostasis in human lupus

剖析 IL-15 在人类狼疮 CD8 T 细胞稳态中的作用

基本信息

  • 批准号:
    8012864
  • 负责人:
  • 金额:
    $ 40.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-02-01 至 2013-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Project Summary/Abstract Systemic lupus erythematosus (SLE) is an autoimmune-mediated inflammatory disease of unknown etiology. The pathologic hallmarks of SLE are altered immune responses to autoantigens with autoantibody production and subsequent tissue injury, with CD4+ T cells as critical drivers of the B cell dependent autoantibody response. Conversely, little is known about the role of CD8+ T cells in the development of lupus, despite the fact that these cells comprise a significant portion of peripheral lymphocytes and play a major role in immune responses via cytotoxicity and cytokine production. Recent studies have shown that expansion of memory CD8+ T cells occurs in patients with SLE, an expansion that is correlated with disease activity, findings that we have replicated in preliminary studies. The mechanism that underlies this expansion, and its implications, are unknown. Logic dictates that the answer to the former question is chronic immune stimulation by autoantigens. Yet previous studies have revealed that T cell proliferation and IL-2 production in response to T cell receptor (TCR) triggering is diminished in human lupus, suggesting a defective, not enhanced, autoantigen-driven response and T cell expansion in disease. Alternatively, but not mutually exclusively, memory CD8+ T cell expansion in lupus could occur independently of antigenic stimulation. Indeed, IL-15 has been emerged as a key cytokine for the maintenance (homeostasis) of memory CD8+ T cells by promotion of cell proliferation and expansion. Thus, the expansion of memory CD8+ T cells in lupus could be driven, at least in part, by IL-15. This notion is supported by the findings of an increase in serum IL-15 levels and expression of IL-15 by monocytes in patients with SLE. What then are the pathological implications of such cell expansion in lupus? IL-15 can promote effector functions of CD8+ T cells including cytokine production and cytotoxicity. Thus, we hypothesize that IL-15 induces expansion of memory CD8+ T cells with pathological implications in patients with SLE. This hypothesis will be addressed with the following specific aims: 1) Determine the mechanisms for memory CD8+ T cell expansion in patients with SLE; 2) Investigate the pathological implications of memory CD8+ T cell expansion in patients with SLE; and 3) Prospectively investigate whether expansion of memory CD8+ T cells correlates with a variety of clinical and biological parameters of SLE. Proving this hypothesis has implications for understanding the pathogenesis of lupus, and potentially could lead to new targets for therapeutic intervention.Project Narrative The goal of the current proposal is to investigate the roles of memory CD8+ T cells and the cytokine IL-15 in the pathogenesis of human lupus. The results of this study will not only aid our understanding of lupus, but will also potentially lead to better diagnostic tools as well as disease monitoring and treatment.
描述(由申请人提供):项目摘要/摘要系统性红斑狼疮(SLE)是一种病因不明的自身免疫介导的炎症性疾病。 SLE 的病理特征是对自身抗原的免疫反应改变,导致自身抗体产生和随后的组织损伤,其中 CD4+ T 细胞是 B 细胞依赖性自身抗体反应的关键驱动因素。相反,人们对 CD8+ T 细胞在狼疮发展中的作用知之甚少,尽管这些细胞构成外周淋巴细胞的很大一部分,并通过细胞毒性和细胞因子产生在免疫反应中发挥重要作用。最近的研究表明,SLE 患者内存​​在 CD8+ T 细胞的扩增,这种扩增与疾病活动性相关,我们在初步研究中也重复了这一发现。这种扩张背后的机制及其影响尚不清楚。从逻辑上讲,前一个问题的答案是自身抗原的慢性免疫刺激。然而之前的研究表明,人类狼疮中响应 T 细胞受体 (TCR) 触发的 T 细胞增殖和 IL-2 产生减少,表明疾病中自身抗原驱动的反应和 T 细胞扩增存在缺陷,而不是增强。或者,但并非相互排斥,狼疮中记忆 CD8+ T 细胞的扩增可能独立于抗原刺激而发生。事实上,IL-15 已成为通过促进细胞增殖和扩张来维持记忆 CD8+ T 细胞(稳态)的关键细胞因子。因此,狼疮中记忆性 CD8+ T 细胞的扩增可能至少部分是由 IL-15 驱动的。 SLE 患者血清 IL-15 水平和单核细胞 IL-15 表达增加的结果支持了这一观点。那么狼疮中这种细胞扩张的病理学意义是什么? IL-15 可以促进 CD8+ T 细胞的效应功能,包括细胞因子的产生和细胞毒性。因此,我们假设 IL-15 会诱导记忆 CD8+ T 细胞的扩增,从而对 SLE 患者产生病理学影响。这一假设将通过以下具体目标来解决:1)确定 SLE 患者记忆 CD8+ T 细胞扩增的机制; 2) 研究SLE患者记忆CD8+ T细胞扩增的病理学意义; 3) 前瞻性研究记忆 CD8+ T 细胞的扩增是否与 SLE 的各种临床和生物学参数相关。证明这一假设对于理解狼疮的发病机制具有重要意义,并可能导致治疗干预的新目标。项目叙述当前提案的目标是研究记忆 CD8+ T 细胞和细胞因子 IL-15 在人类狼疮发病机制中的作用。这项研究的结果不仅有助于我们了解狼疮,而且还可能带来更好的诊断工具以及疾病监测和治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Edgar Craft其他文献

Joseph Edgar Craft的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Edgar Craft', 18)}}的其他基金

A novel Lyme disease vaccine
一种新型莱姆病疫苗
  • 批准号:
    10515700
  • 财政年份:
    2022
  • 资助金额:
    $ 40.55万
  • 项目类别:
A novel Lyme disease vaccine
一种新型莱姆病疫苗
  • 批准号:
    10640164
  • 财政年份:
    2022
  • 资助金额:
    $ 40.55万
  • 项目类别:
Human and Translational Immunology Training Program
人类和转化免疫学培训计划
  • 批准号:
    10649548
  • 财政年份:
    2021
  • 资助金额:
    $ 40.55万
  • 项目类别:
Human and Translational Immunology Training Program
人类和转化免疫学培训计划
  • 批准号:
    10270035
  • 财政年份:
    2021
  • 资助金额:
    $ 40.55万
  • 项目类别:
Human and Translational Immunology Training Program
人类和转化免疫学培训计划
  • 批准号:
    10474483
  • 财政年份:
    2021
  • 资助金额:
    $ 40.55万
  • 项目类别:
Pathogenesis of Lupus Nephritis
狼疮性肾炎的发病机制
  • 批准号:
    10612792
  • 财政年份:
    2020
  • 资助金额:
    $ 40.55万
  • 项目类别:
Pathogenesis of Lupus Nephritis
狼疮性肾炎的发病机制
  • 批准号:
    10159199
  • 财政年份:
    2020
  • 资助金额:
    $ 40.55万
  • 项目类别:
Pathogenesis of Lupus Nephritis
狼疮性肾炎的发病机制
  • 批准号:
    10396047
  • 财政年份:
    2020
  • 资助金额:
    $ 40.55万
  • 项目类别:
Follicular Helper T Cell Function in Autoimmunity
滤泡辅助 T 细胞在自身免疫中的功能
  • 批准号:
    10320436
  • 财政年份:
    2018
  • 资助金额:
    $ 40.55万
  • 项目类别:
Follicular Helper T Cell Function in Autoimmunity
滤泡辅助 T 细胞在自身免疫中的功能
  • 批准号:
    10061557
  • 财政年份:
    2018
  • 资助金额:
    $ 40.55万
  • 项目类别:

相似海外基金

Defining the cellular origin of pathogenic autoantibodies
定义致病性自身抗体的细胞起源
  • 批准号:
    EP/Y031091/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
  • 批准号:
    MR/Y022947/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Operating Grants
Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer
肿瘤衍生新表位的自身抗体作为生物标志物和免疫 PET 试剂用于小细胞肺癌的早期检测
  • 批准号:
    10715807
  • 财政年份:
    2023
  • 资助金额:
    $ 40.55万
  • 项目类别:
Role of pharmacological activity of autoantibodies in ME/CFS
自身抗体药理活性在 ME/CFS 中的作用
  • 批准号:
    MR/Y003667/1
  • 财政年份:
    2023
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Research Grant
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
  • 批准号:
    10740682
  • 财政年份:
    2023
  • 资助金额:
    $ 40.55万
  • 项目类别:
Sjogren's Syndrome Pathogenic Autoantibodies
干燥综合征致病性自身抗体
  • 批准号:
    10854472
  • 财政年份:
    2023
  • 资助金额:
    $ 40.55万
  • 项目类别:
Pathogenesis of idiopathic nephrotic syndrome: defining the role of B cells and autoantibodies reactive to podocyte proteins
特发性肾病综合征的发病机制:定义 B 细胞和足细胞蛋白反应性自身抗体的作用
  • 批准号:
    487849
  • 财政年份:
    2023
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Operating Grants
Analysis of pathogenesis associated with mutation of complement associated gene and autoantibodies in development/progression of C3 nephropathy.
补体相关基因突变和自身抗体在C3肾病发生/进展中的发病机制分析。
  • 批准号:
    22K08309
  • 财政年份:
    2022
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Depleting autoantibodies for the treatment of autoimmunity
消耗自身抗体来治疗自身免疫
  • 批准号:
    10481071
  • 财政年份:
    2022
  • 资助金额:
    $ 40.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了